# enGene Therapeutics Inc.: Form 8-K, filed Oct 2, 2025

- Company: [enGene Therapeutics Inc.](/companies/engn.md) (CIK 1980845)
- Form: 8-K
- Filed: 2025-10-02
- Accepted by EDGAR: Oct 2, 2025, 16:15 ET
- Period: 2025-10-02
- Accession: 0001193125-25-228351
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1980845/000119312525228351/engn-20251002.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1980845/000119312525228351/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1980845/000119312525228351/engn-20251002.htm

Filed Oct 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-228351. Last ingested by Listed: Nov 14, 2026, 22:37 ET. No prices; not investment advice.
